Shenghe Wanwu (Suzhou) Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shenghe Wanwu (Suzhou) Biotechnology - overview
Established
2021
Location
Suzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Suzhou, China, and founded in 2021, Shenghe Wanwu (Suzhou) Biotechnology is a biotechnology company that provides various natural compounds. The core team comes from the Chinese Academy of Sciences, which has rich experience in synthetic biological research of natural plant compounds. Through biosynthesis preparation technology, it can achieve the production of various monomeric components of ginsenosides, which can be used in pharmaceuticals, health products, functional foods, and cosmetics.
Current Investors
Addor Capital, Zhongke Angel Fund, JP Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.